These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5312512)

  • 1. Influence of human milk on the development of antistaphylococcal immunity.
    Sengers RC
    Antonie Van Leeuwenhoek; 1970; 36(3):349-56. PubMed ID: 5312512
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental infection of mice with Staphylococcus aureus: evidence against alpha toxin and the terminal size of the bacterial population as determinants of lethality.
    Bartell PF; Orr TE; Geffen A; Iorio P
    J Infect Dis; 1968 Dec; 118(5):481-90. PubMed ID: 4236131
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity in mice infected with S. aureus and elicited with specific bacterial antigens.
    Shayegani M; De Courcy SJ; Mudd S
    J Reticuloendothel Soc; 1973 Jul; 14(1):44-51. PubMed ID: 4744532
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the protective effect of human milk and cow's milk fractions as well as various oils and unsaturated fatty acids in experimental staphylococcal infection in mice. I. Results of animal experiment protective trials].
    Schmidt E; Butt W; Caliebe H; Pulverer G
    Z Kinderheilkd; 1967; 99(1):65-78. PubMed ID: 5595470
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to surface antigens of Staphylococcus aureus and their role in resistance to staphylococcal disease.
    Ekstedt RD
    Ann N Y Acad Sci; 1974 Jul; 236(0):203-20. PubMed ID: 4214129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of alloxan diabetes in staphylococcal infection in mice].
    Iván E; Gábor R; Hernádi F
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):109-12. PubMed ID: 4454833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of antistaphylococcal immune preparations in acute suppurative-septic staphylococcal diseases].
    Krotova TA; Smirnova AI; Aftenko TV
    Vrach Delo; 1979 Sep; (9):106-9. PubMed ID: 91270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infection and immunity of Staphylococcus aureus with special reference to the role of capsule and capsular substance in experimental staphylococcal infection].
    Yoshida K
    Nihon Saikingaku Zasshi; 1970 Jul; 25(7):335-42. PubMed ID: 4918039
    [No Abstract]   [Full Text] [Related]  

  • 9. Gonococcal enhancement of staphylococcal virulence for the mouse.
    Flynn J; McEntegart MG
    J Med Microbiol; 1973 Aug; 6(3):371-6. PubMed ID: 4199270
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of staphylococcal protein A immunomodulation.
    Silverman GJ; Goodyear CS; Siegel DL
    Transfusion; 2005 Feb; 45(2):274-80. PubMed ID: 15660839
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of capsular-type of Staphylococcus epidermidis to virulence and induction of resistance in the mouse.
    Ichiman Y; Yoshida K
    J Appl Bacteriol; 1981 Oct; 51(2):229-41. PubMed ID: 7298531
    [No Abstract]   [Full Text] [Related]  

  • 12. Capsule production and virulence among strains of Staphylococcus aureus.
    Wiley BB; Maverakis NH
    Ann N Y Acad Sci; 1974 Jul; 236(0):221-32. PubMed ID: 4138896
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of easily released substances (ERS) from bacteria into physiologic solutions in natural immunity. III. Some properties of ERS from Staphylococcus aureus.
    Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):563-9. PubMed ID: 4447445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antistaphylococcal immunity in patients with chronic suppurative sinusitis treated with levamisole and intal].
    Zabolotnyĭ DI; Volosevich LI
    Vestn Otorinolaringol; 1985; (6):47-9. PubMed ID: 3937311
    [No Abstract]   [Full Text] [Related]  

  • 15. The production of subcutaneous staphylococcal skin lesions in mice.
    Noble WC
    Br J Exp Pathol; 1965 Jun; 46(3):254-62. PubMed ID: 5829388
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance against Staphylococcus aureus.
    Mudd S
    JAMA; 1971 Dec; 218(11):1671-3. PubMed ID: 5171042
    [No Abstract]   [Full Text] [Related]  

  • 17. Virulence of staphylococci to mice and its relation to lysozyme production and coagulase activity.
    Selim SA; Osman KM; Ismail M; Mohamed SM; Morgan SD
    Arch Exp Veterinarmed; 1984 Sep; 38(5):692-6. PubMed ID: 6529329
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the subcutaneous abscess formation and immunity in staphylococcal infection of mice.
    Tadokoro I
    Jpn J Exp Med; 1966 Feb; 36(1):6passim. PubMed ID: 5297258
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse virulent strain of Staphylococcus epidermidis. Relation of antiphagocytic activity to the protection-inducing antigen.
    Yoshida K; Ichiman Y; Ohtomo T
    Jpn J Microbiol; 1976 Jun; 20(3):209-17. PubMed ID: 61300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antistaphylococcal immunity in chronic polypous rhinosinusitis].
    Leont'eva TN; Anikina TP
    Vestn Otorinolaringol; 1979; (6):50-3. PubMed ID: 516241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.